LFA Center for Clinical Trials Education
The LFA has established the Center for Clinical Trials Education (CCTE) to provide information for anyone who may be interested in participating in a clinical trial of a potential new treatment for lupus. The website includes a search function that allows trials to be identified in specific geographic areas. Click here for more information.
Lupus Trials Listed on ClinicalTrials.gov
ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research. ClinicalTrials.gov provides information about clinical trials and their purpose, as well as information about who may participate, study locations, and contact information for more details.Click here for more information.
Dallas Clinical Trials
Kezar Life Sciences Clinical Trials
Clinical Trials for KZR-616 KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis
To learn more about participating in our clinical trials, please email firstname.lastname@example.org.
MCRC Clinical Research Study
A clinical research study is under way to evaluate a new investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent. If you have SLE, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:
- Are between the ages of 18 and 70
- Have been diagnosed with lupus ≥ 24 weeks
Qualified participants will receive study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required. You will be asked to complete up to 16 clinic visits over a 64 week period. Compensation for time and travel may be provided if you qualify for the study.
To find out more about this clinical research study please contact MCRC at 214-424-0405.